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Staphylococcus epidermidis, a normal inhabitant of healthy human skin and mucosae, can cause persistent 
and relapsing infections due to its ability to adhere to medical devices and form biofilms. Hence, S. 
epidermidis is considered one of the most important medical device-associated nosocomial agents, being 
particularly associated with vascular catheters. Although the biofilms formed on these catheters are in 
constant contact with human blood, their mutual interaction is poorly understood. Here, we evaluated the 
expression of genes associated with biofilm formation (icaA, aap, bhp), immune evasion (icaA, mprF, sepA) 
and programmed cell death (lrgB), as well as biofilm structure and viability, upon bacterial interaction with 
human blood and its components. We observed that contact with human blood increased the transcription of 
icaA and bhp but decreased aap, sepA and lrgB gene expression, when compared with plasma. In contrast, 
no significant transcriptional alterations were detected upon contact with purified mononuclear cells, 
whereas purified polymorphonuclear cells lead to increased bhp and mprF gene expression. Furthermore, 
human blood reduced by 50% the number of viable cells within the biofilm and induced significant 
alterations in its structure, with the creation of a fibre-like matrix. In conclusion, our study reveals that S. 
epidermis biofilms adapt to particular environmental stress by changing the expression of specific genes and 
by altering their structure. Despite these overall observations, significant variability was found between 
different blood donors, suggesting that particularities of the host immune system may strongly affect the 
outcome of S. epidermidis infections. 
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Dormant bacteria within biofilms contribute to biofilm heterogeneity. Consequently, physiological 
heterogeneity of biofilms may influence host immune response and tolerance to antibiotics. Recently, we 
described an in vitro model to modulate dormancy in S. epidermidis biofilms. Here, we present a study based 
on immunoproteomics, where we compared the reactive profile of  S. epidermidis biofilm proteins with 
prevented and induced dormancy, to human sera. A total of 19 immunoreactive proteins were identified by 
MALDI-TOF/TOF. Most of these proteins present molecular functions, such as catalytic activity and ion 
binding. CodY and GpmA proteins were more reactive to sera when biofilm dormancy was induced, while 
FtnA and ClpP were more reactive when dormancy was prevented. This is the first work identifying protein 
immunoreactivity differences between bacterial biofilms with induced or prevented dormancy. Considering 
the importance of dormancy within biofilms, further studies on these proteins may provide insights into the 
mechanisms related to dormancy and help improving current understanding on how dormancy affects the 
host immune response. 
  
